NMN-mediated longevity and the main reasons for decreasing NAD+ level with age
Hypothetical model of NMN-mediated longevity and the main reasons for decreasing NAD+ level with age. NMN may exploit the mechanism for lifespan extension by mitohormesis, which may depend on the AMPK/SIRT1/FOXO pathway. On the other hand, NAD+ degradation accelerates due to DNA damage, chronic oxidative stress, inflammation and consumption of higher NAD+ enzymes such as sirtuins, CD38, CD157, TNKS, poly-adenosine diphosphate ribose polymerase, etc. When NAD+ levels decrease, dysregulation of mitochondrial energy production may occur, leading to aging and decreasing lifespan extension. Supplementation with NMN reverses the aging process, promotes NAD+ levels, and prevents age-related disorders
Publication
Role and Potential Mechanisms of Nicotinamide Mononucleotide in Aging (2024) Sajid Ur Rahman, et al. Aging Dis. 2024 Apr 1;15(2). Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | TNKS | TNKS | ncbigene_symbol | TNKS | 8658 |
| Homo sapiens | Primates | PARP | PARP | ncbigene_synonym | PARP1 | 142 |
| Homo sapiens | Primates | PARP | PARP | ncbigene_synonym | COL11A2 | 1302 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP2 | 10038 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP3 | 10039 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP4 | 143 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP6 | 56965 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP8 | 79668 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP9 | 83666 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP10 | 84875 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP11 | 57097 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP12 | 64761 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP14 | 54625 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP15 | 165631 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | PARP16 | 54956 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | TNKS2 | 80351 |
| Homo sapiens | Primates | PARP | PARP | famplex_relations | TIPARP | 25976 |
| Homo sapiens | Primates | CD38/CD157 | CD157 | ncbigene_synonym | BST1 | 683 |
| Homo sapiens | Primates | CD38/CD157 | CD38 | ncbigene_symbol | CD38 | 952 |
| Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAA1 | 5562 |
| Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAA2 | 5563 |
| Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAB1 | 5564 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAB2 | 5565 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG1 | 5571 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG2 | 51422 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG3 | 53632 |
| Homo sapiens | Primates | SIRT1/SIR-2.1- | SIRT1 | ncbigene_symbol | SIRT1 | 23411 |
| Homo sapiens | Primates | FOXO/DAF-16 | FOXO | famplex_relations | FOXO1 | 2308 |
| Homo sapiens | Primates | FOXO/DAF-16 | FOXO | famplex_relations | FOXO3 | 2309 |
| Homo sapiens | Primates | FOXO/DAF-16 | FOXO | famplex_relations | FOXO4 | 4303 |
| Homo sapiens | Primates | FOXO/DAF-16 | FOXO | famplex_relations | FOXO6 | 100132074 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| PARP | PARP | chebi:62913 | ||
| cyclic ADP-ribose | cyclic ADP-ribose | chebi:31445 | ||
| NMN | NMN | 3-carbamoyl-1-[5-O-(hydroxyphosphinato)-beta-D-ribofuranosyl]pyridinium | chebi:16171 | |
| NAD+ | NAD+ | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 | |
| NAD+ | NAD+ | adenosine 5'-{3-[1-(3-carbamoylpyridinio)-1,4-anhydro-D-ribitol-5-yl] dihydrogen diphosphate} | chebi:15846 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|